| Estimating life years lost to diabetes: outcomes from analysis of National Diabetes Audit and Office of National Statistics data AH Heald, M Stedman, M Davies, M Livingston, R Alshames, M Lunt, ... Cardiovascular endocrinology & metabolism 9 (4), 183-185, 2020 | 183 | 2020 |
| “Stay at Home, Protect the National Health Service, Save Lives”: A cost benefit analysis of the lockdown in the United Kingdom DK Miles, M Stedman, AH Heald International Journal of Clinical Practice 75 (3), e13674, 2021 | 122 | 2021 |
| Living with COVID-19: balancing costs against benefits in the face of the virus D Miles, M Stedman, A Heald National Institute Economic Review 253, R60-R76, 2020 | 120 | 2020 |
| Cost of hospital treatment of type 1 diabetes (T1DM) and type 2 diabetes (T2DM) compared to the non-diabetes population: a detailed economic evaluation M Stedman, M Lunt, M Davies, M Livingston, C Duff, A Fryer, ... BMJ open 10 (5), e033231, 2020 | 65 | 2020 |
| Personal protective equipment (PPE) and infection among healthcare workers–What is the evidence? Z Tian, M Stedman, M Whyte, SG Anderson, G Thomson, A Heald International journal of clinical practice 74 (11), e13617, 2020 | 63 | 2020 |
| Modelling the impact of the mandatory use of face coverings on public transport and in retail outlets in the UK on COVID‐19‐related infections, hospital admissions and mortality AH Heald, M Stedman, Z Tian, P Wu, AA Fryer International journal of clinical practice 75 (3), e13768, 2021 | 48 | 2021 |
| A phased approach to unlocking during the COVID‐19 pandemic—lessons from trend analysis M Stedman, M Davies, M Lunt, A Verma, SG Anderson, AH Heald International journal of clinical practice 74 (8), e13528, 2020 | 41 | 2020 |
| Improving type 2 diabetes mellitus glycaemic outcomes is possible without spending more on medication: lessons from the UK National Diabetes Audit AH Heald, M Livingston, N Malipatil, M Becher, J Craig, M Stedman, ... Diabetes, Obesity and Metabolism 20 (1), 185-194, 2018 | 40 | 2018 |
| Assessment of the effect of the COVID-19 pandemic on UK HbA1c testing: implications for diabetes management and diagnosis D Holland, AH Heald, M Stedman, F Hanna, P Wu, C Duff, L Green, ... Journal of Clinical Pathology 76 (3), 177-184, 2023 | 31 | 2023 |
| Antidepressant prescribing in England: patterns and costs AH Heald, M Stedman, M Davies, M Livingston, D Taylor, R Gadsby The Primary Care Companion for CNS Disorders 22 (2), 26631, 2020 | 29 | 2020 |
| Route to improving Type 1 diabetes mellitus glycaemic outcomes: real‐world evidence taken from the National Diabetes Audit AH Heald, M Livingston, A Fryer, GYC Moreno, N Malipatil, R Gadsby, ... Diabetic Medicine 35 (1), 63-71, 2018 | 29 | 2018 |
| The change in glycaemic control immediately after COVID‐19 vaccination in people with type 1 diabetes AH Heald, M Stedman, L Horne, R Rea, M Whyte, JM Gibson, ... Diabetic medicine 39 (4), e14774, 2022 | 26 | 2022 |
| How fast should social restrictions be eased in England as COVID‐19 vaccinations are rolled out? DK Miles, AH Heald, M Stedman International journal of clinical practice 75 (7), e14191, 2021 | 22 | 2021 |
| Analysis of continuous blood glucose data in people with type 1 diabetes (T1DM) after COVID-19 vaccination indicates a possible link between the immune and the metabolic response AH Heald, M Stedman, L Horne, R Rea, M Whyte, JM Gibson, ... Journal of diabetes science and technology 15 (5), 1204-1205, 2021 | 18 | 2021 |
| Impact of the UK COVID-19 pandemic on HbA1c testing and its implications for diabetes diagnosis and management. D Holland, AH Heald, M Stedman, L Green, J Scargill, P Wu, CJ Duff, ... International journal of clinical practice 75, 2021 | 18 | 2021 |
| Analysis of continuous glucose tracking data in people with type 1 diabetes after COVID‐19 vaccination reveals unexpected link between immune and metabolic response, augmented … AH Heald, R Rea, L Horne, A Metters, T Steele, K Leivesley, MB Whyte, ... International Journal of Clinical Practice 75 (12), e14714, 2021 | 17 | 2021 |
| Reducing fatigue-related symptoms in Long COVID-19: a preliminary report of a lymphatic drainage intervention AH Heald, R Perrin, A Walther, M Stedman, M Hann, A Mukherjee, L Riste Cardiovascular endocrinology & metabolism 11 (2), e0261, 2022 | 16 | 2022 |
| The costs of drug prescriptions for diabetes in the NHS M Stedman, M Lunt, M Livingston, AA Fryer, G Moreno, S Bailey, ... The Lancet 393 (10168), 226-227, 2019 | 16 | 2019 |
| Mortality rate associated with diabetes: outcomes from a general practice level analysis in England using the Royal College of General Practitioners (RCGP) database indicate … A Heald, M Stedman, A Robinson, M Davies, M Livingston, R Alshames, ... Diabetes Therapy 13 (3), 505-516, 2022 | 12 | 2022 |
| Trends in costs and prescribing for liothyronine and levothyroxine in England and wales 2011–2020 M Stedman, P Taylor, L Premawardhana, O Okosieme, C Dayan, ... Clinical Endocrinology 94 (6), 980-989, 2021 | 12 | 2021 |
